ArticleInvestigational new drugs2021

A first-in-human, phase 1 study of the NEDD8 activating enzyme E1 inhibitor TAS4464 in patients with advanced solid tumors.

Noboru Yamamoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.